Literature DB >> 143363

Prazosin: a review of its pharmacological properties and therapeutic efficacy in hypertension.

R N Brogden, R C Heel, T M Speight, G S Avery.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 143363     DOI: 10.2165/00003495-197714030-00002

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  69 in total

1.  Letter: Adverse reactions to prazosin.

Authors:  R Gabriel; D Meek; H Hamtora
Journal:  Br Med J       Date:  1975-10-04

2.  Prescribing prazosin.

Authors:  A S Turner
Journal:  N Z Med J       Date:  1976-07-14

3.  The kidney and antihypertensive therapy.

Authors:  R R Bailey
Journal:  Drugs       Date:  1976       Impact factor: 9.546

4.  Variability in effect of low doses of prozosin in hypertensive Nigerians.

Authors:  O V Oviasu; P E Idahosa
Journal:  Curr Ther Res Clin Exp       Date:  1976-12

5.  Clinical evaluation of prazosin as the sole agent for the treatment of hypertension: a double-blind cross-over study with methyldopa.

Authors:  D S Bloom; C Rosendorff; R Kramer
Journal:  Curr Ther Res Clin Exp       Date:  1975-07

6.  Prazosin: the first-dose phenomenon.

Authors:  R M Graham; I R Thornell; J M Gain; C Bagnoli; H F Oates; G S Stokes
Journal:  Br Med J       Date:  1976-11-27

7.  A new look at the treatment of severe hypertension.

Authors:  P Kincaid-Smith; P Fang; M C Laver
Journal:  Clin Sci Mol Med Suppl       Date:  1973-08

8.  Prazosin alone and combined with a thiazide diuretic in the treatment of hypertension.

Authors:  Y K Seedat; M A Seedat; R Bhoola
Journal:  S Afr Med J       Date:  1977-04-02

9.  Prazosin in the treatment of hypertension.

Authors:  M Fernandes; I S Smith; A Weder; K E Kim; A B Gould; P Busby; C Swartz; G Onesti
Journal:  Clin Sci Mol Med Suppl       Date:  1975-06

10.  A phase II study of prazosin hydrochloride in hypertensive subjects.

Authors:  R R Paul; P L Sharma; P L Wahi
Journal:  Int J Clin Pharmacol Biopharm       Date:  1976-12
View more
  38 in total

Review 1.  Advances in the design and synthesis of prazosin derivatives over the last ten years.

Authors:  Andreas Desiniotis; Natasha Kyprianou
Journal:  Expert Opin Ther Targets       Date:  2011-12-13       Impact factor: 6.902

2.  Dose-titration study of alfuzosin, a new alpha 1-adrenoceptor blocker, in essential hypertension.

Authors:  S Leto di Priolo; P Priore; G Cocco; C Sfrisi; J L Cazor
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

3.  The pharmacokinetics of doxazosin in patients with hypertension and renal impairment.

Authors:  R M Oliver; J W Upward; A G Dewhurst; R Honeywell; A G Renwick; D G Waller
Journal:  Br J Clin Pharmacol       Date:  1990-04       Impact factor: 4.335

4.  Drug interactions with antihypertensive drugs.

Authors:  J E Crook; A S Nies
Journal:  Drugs       Date:  1978-01       Impact factor: 9.546

Review 5.  Antihypertensive drugs: clinical pharmacology and therapeutic use.

Authors:  G L Wollam; R W Gifford; R C Tarazi
Journal:  Drugs       Date:  1977-12       Impact factor: 9.546

6.  A comparison of labetalol and prazosin combined with atenolol in non-responders to atenolol plus hydrochlorothiazide in uncomplicated hypertension.

Authors:  E van der Veur; B S ten Berge; A J Donker; J F May; F H Schuurman; H Wesseling
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

7.  Prazosin depression of baroreflex function in hypertensive man.

Authors:  E H Sasso; D T O'Connor
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

8.  Within patient comparison of prazosin and UK-33,274. A new alpha-adrenoceptor-antagonist.

Authors:  P W de Leeuw; J J Ligthart; A J Smout; W H Birkenhäger
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

9.  Comparison of vasodilator drug prazosin with digoxin in aortic regurgitation.

Authors:  B E Hockings; G D Cope; G M Clarke; R R Taylor
Journal:  Br Heart J       Date:  1980-05

10.  Prazosin, pharmacokinetics and concentration effect.

Authors:  D N Bateman; D C Hobbs; T M Twomey; E A Stevens; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.